id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-N-0032-0031,FDA,FDA-2008-N-0032,"Supplemental Applications Proposing Labeling Changes for Approved Drugs, Biologics, and Medical Devices",Rule,NFR-Notice of Final Rule,2008-08-22T04:00:00Z,2008,8,,,2011-06-11T16:27:11Z,E8-19572,0,0,09000064806d303d
FDA-2008-N-0032-0030,FDA,FDA-2008-N-0032,Congress of the United States [The Honorable Paul E. Kanjorski] - Letter,Other,LET-Letter,2008-07-16T04:00:00Z,2008,7,2008-07-16T04:00:00Z,,2008-07-16T22:31:50Z,,0,0,09000064806652eb
FDA-2008-N-0032-0028,FDA,FDA-2008-N-0032,FDA Response [Office of Legislation] to the Honorable Joseph I. Lieberman - Letter,Other,LET-Letter,2008-06-16T04:00:00Z,2008,6,2008-06-16T04:00:00Z,,2008-06-16T15:54:44Z,,0,0,0900006480620e0d
FDA-2008-N-0032-0023,FDA,FDA-2008-N-0032,FDA Response [Office of Legislation] to The Honorable Henry A. Waxman - Letter,Other,LET-Letter,2008-03-20T04:00:00Z,2008,3,2008-01-16T05:00:00Z,2008-03-18T03:59:59Z,2013-08-11T02:30:48Z,,0,0,09000064804019ac
FDA-2008-N-0032-0001,FDA,FDA-2008-N-0032,"Supplemental Applications Proposing Labeling Changes for Approved Drugs, Biologics, and Medical Devices",Proposed Rule,NPR-Notice of Proposed Rule-Making,2008-01-16T05:00:00Z,2008,1,2008-01-16T05:00:00Z,2008-03-18T03:59:59Z,2011-06-11T16:27:12Z,E8-00702,0,0,090000648039b887